论文部分内容阅读
由复旦大学附属肿瘤医院联合全国12家研究中心完成的一项原创性临床研究——吉西他滨联合顺铂的化疗方案,可显著延长转移性三阴性乳腺癌患者的生存期。相关研究成果日前发表于《柳叶刀—肿瘤学》。该院胡夕春教授、张剑医生等自2011年起,将240名年龄分布在18岁~70岁、病程处于复发转移阶段且未行化疗的三阴性乳腺癌患者,随
An original clinical study, gemcitabine combined with cisplatin chemotherapy, was conducted by 12 affiliated research centers affiliated to Fudan University Cancer Hospital and significantly prolonged the survival of patients with metastatic triple negative breast cancer. Relevant research results recently published in the “Lancet - Oncology.” The hospital Professor Hu Xichun, Dr. Zhang Jian and other since 2011, the 240 age distribution in 18 years old to 70 years old, the course of the disease is in the stage of recurrence and metastasis without chemotherapy in triple negative breast cancer patients, with